APOA5 and hepatocellular carcinoma: Indeed, studies with APOA5 transgenic mice revealed that apoA5 expression influences intrahepatic TG accumulation [76], and Ress et al. also demonstrated that knockdown of APOA5 in human hepatoma cells resulted in decrease in intracellular TG content (Fig. 2a) [30].